Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Statement re Northgate plc

4 Jul 2016 16:09

CRYSTAL AMBER FUND LIMITED - Statement re Northgate plc

CRYSTAL AMBER FUND LIMITED - Statement re Northgate plc

PR Newswire

London, July 4

4 July 2016

Crystal Amber Fund Limited

(the “Company”)

Statement re Northgate plc (“Northgate”)

Earlier today, it was disclosed that Crystal Amber Fund Limited (“Crystal Amber”) had acquired a disclosable interest of 3 per cent of the issued share capital of Northgate. In September 2012, Crystal Amber invested in Northgate and following successful engagement, exited the position in April 2015. Since then, Northgate’s share price has fallen by approximately 50%. The shares currently trade at a discount to the net asset value as at 30 April 2016 and yield in excess of 5% (based on the proposed final dividend of 10.9p per share).

Last week, Crystal Amber’s investment adviser met with Bob Contreras, Chief Executive of Northgate. Today, Crystal Amber has written to Northgate, setting out its assessment of the company’s prospects together with suggested actions so that stakeholders can better capitalise on the Northgate brand, market positioning, strong cash generation and balance sheet strength. Amongst its proposals, Crystal Amber has requested that Northgate carries out a strategic review to include a potential sale of all or part of the business.

For further enquiries please contact: Crystal Amber Fund Limited William Collins (Chairman) Tel: 01481 716 000 Allenby Capital Limited - Nominated Adviser David Worlidge/James Thomas Tel: 020 7167 6431 Numis Securities Limited - Broker Nathan Brown/Hugh Jonathan Tel: 020 7260 1426 Crystal Amber Advisers (UK) LLP – Investment Adviser Richard Bernstein Tel: 020 7478 9080
Date   Source Headline
10th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20255:11 pmRNSForm 8.3 - De La Rue plc
6th Feb 20255:32 pmRNSTransaction in Own Shares and Total Voting Rights
6th Feb 202510:56 amRNSHolding(s) in Company
5th Feb 20255:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20255:16 pmRNSForm 8.3 - De La Rue plc - Replacement
4th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 202511:30 amRNSForm 8.3 - De La Rue plc
3rd Feb 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
31st Jan 20255:44 pmRNSTotal Voting Rights
31st Jan 20252:04 pmRNSHolding(s) in Company
30th Jan 20255:43 pmRNSForm 8.3 - De La Rue plc
30th Jan 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20258:52 amRNSForm 8.3 - De La Rue plc
30th Jan 20257:27 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20257:00 amRNSShare Buyback Programme
28th Jan 20256:24 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jan 20255:28 pmRNSForm 8.3 - De La Rue plc
28th Jan 20259:45 amRNSTransaction in Own Shares and TVR - Replacement
28th Jan 20259:45 amRNSTransaction in Own Shares and TVR - Replacement
28th Jan 20258:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20254:56 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 20252:10 pmRNSMonthly Net Asset Value
21st Jan 20257:00 amRNSForm 8.3 - De La Rue plc
20th Jan 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20257:00 amRNSForm 8.3 - De La Rue plc
17th Jan 20257:00 amRNSForm 8.3 - De La Rue plc
16th Jan 202511:00 amRNSForm 8.3 - De La Rue plc
15th Jan 20255:45 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20256:23 pmRNSConversion of loan notes in Morphic - Replacement
13th Jan 20257:00 amRNSConversion of loan notes in Morphic Medical Inc.
9th Jan 20255:46 pmRNSTransaction in Own Shares and Total Voting Rights
8th Jan 202510:45 amRNSForm 8.3 - De La Rue plc
27th Dec 20247:00 amRNSForm 8.3 - De La Rue plc
19th Dec 202412:00 pmRNSMonthly Net Asset Value
13th Dec 202410:58 amRNSResult of AGM
3rd Dec 20247:00 amRNSFurther investment into Morphic Medical Inc
19th Nov 20244:50 pmRNSMonthly Net Asset Value
18th Nov 20242:58 pmRNSMonthly Net Asset Value
13th Nov 20247:00 amRNSPosting of Annual Report and Notice of AGM
12th Nov 20247:00 amRNSFinal Results
28th Oct 20242:23 pmRNSResult of Extraordinary General Meeting
9th Oct 20247:00 amRNSProposed B share scheme and notice of GM
1st Oct 20241:24 pmRNSMonthly Net Asset Value
11th Sep 20241:11 pmRNSMonthly Net Asset Value
30th Aug 20245:30 pmRNSTotal Voting Rights
23rd Aug 20249:04 amRNSHolding(s) in Company
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20244:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.